Literature DB >> 15331427

Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse.

Matthias H Kapturczak1, Clive Wasserfall, Todd Brusko, Martha Campbell-Thompson, Tamir M Ellis, Mark A Atkinson, Anupam Agarwal.   

Abstract

Induction of heme oxygenase-1 (HO-1) is protective in tissue injury in models of allograft rejection and vascular inflammation through either prevention of oxidative damage or via immunomodulatory effects. To examine the specific role of HO-1 in modulating the immune response, we examined the differences in immune phenotype between HO-1 knockout (HO-1(-/-)) and wild-type (HO-1(+/+)) mice. Consistent with previous findings, marked splenomegaly and fibrosis were observed in HO-1(-/-) mice. The lymph nodes of HO-1-deficient mice demonstrated a relative paucity of CD3- and B220-positive cells, but no such abnormalities were observed in the thymus. Flow cytometric analysis of isolated splenocytes demonstrated no differences in the proportions of T lymphocytes, B lymphocytes or monocytes/macrophages between the HO-1(-/-) and HO-1(+/+) mice. Significantly higher baseline serum IgM levels were observed in HO-1(-/-) versus HO-1(+/+) mice. Under mitogen stimulation with either lipopolysaccharide or anti-CD3/anti-CD28, HO-1(-/-) splenocytes secreted disproportionately higher levels of pro-inflammatory Th1 cytokines as compared to those from HO-1(+/+) mice. These findings demonstrate significant differences in the immune phenotype between the HO-1(-/-) and the HO-1(+/+) mice. The absence of HO-1 correlates with a Th1-weighted shift in cytokine responses suggesting a general pro-inflammatory tendency associated with HO-1 deficiency.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15331427      PMCID: PMC1618611          DOI: 10.1016/S0002-9440(10)63365-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  51 in total

Review 1.  Heme oxygenase-1 in renal injury: conclusions of studies in humans and animal models.

Authors:  Y S Kanwar
Journal:  Kidney Int       Date:  2001-01       Impact factor: 10.612

2.  Heme oxygenase-1 gene therapy: a novel immunomodulatory approach in liver allograft recipients?

Authors:  B Ke; X D Shen; J Melinek; F Gao; T Ritter; H D Volk; R W Busuttil; J W Kupiec-Weglinski
Journal:  Transplant Proc       Date:  2001 Feb-Mar       Impact factor: 1.066

3.  Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL.

Authors:  K Ishikawa; M Navab; N Leitinger; A M Fogelman; A J Lusis
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

4.  Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia.

Authors:  T Minamino; H Christou; C M Hsieh; Y Liu; V Dhawan; N G Abraham; M A Perrella; S A Mitsialis; S Kourembanas
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

5.  Heme protein-induced chronic renal inflammation: suppressive effect of induced heme oxygenase-1.

Authors:  K A Nath; G M Vercellotti; J P Grande; H Miyoshi; C V Paya; J C Manivel; J J Haggard; A J Croatt; W D Payne; J Alam
Journal:  Kidney Int       Date:  2001-01       Impact factor: 10.612

6.  Reduced stress defense in heme oxygenase 1-deficient cells.

Authors:  K D Poss; S Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

7.  Heme oxygenase 1 is required for mammalian iron reutilization.

Authors:  K D Poss; S Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

8.  Heme induces the expression of adhesion molecules ICAM-1, VCAM-1, and E selectin in vascular endothelial cells.

Authors:  F A Wagener; E Feldman; T de Witte; N G Abraham
Journal:  Proc Soc Exp Biol Med       Date:  1997-12

9.  Heme oxygenase-1 protects against vascular constriction and proliferation.

Authors:  H J Duckers; M Boehm; A L True; S F Yet; H San; J L Park; R Clinton Webb; M E Lee; G J Nabel; E G Nabel
Journal:  Nat Med       Date:  2001-06       Impact factor: 53.440

10.  Transfer of heme oxygenase 1 cDNA by a replication-deficient adenovirus enhances interleukin 10 production from alveolar macrophages that attenuates lipopolysaccharide-induced acute lung injury in mice.

Authors:  S Inoue; M Suzuki; Y Nagashima; S Suzuki; T Hashiba; T Tsuburai; K Ikehara; T Matsuse; Y Ishigatsubo
Journal:  Hum Gene Ther       Date:  2001-05-20       Impact factor: 5.695

View more
  154 in total

1.  Naive human T cells are activated and proliferate in response to the heme oxygenase-1 inhibitor tin mesoporphyrin.

Authors:  Trevor D Burt; Lillian Seu; Jeffrey E Mold; Attallah Kappas; Joseph M McCune
Journal:  J Immunol       Date:  2010-10-04       Impact factor: 5.422

2.  Blocking effect of a monoclonal antibody against recombinant Pvs25 on sporozoite development in Anopheles sinensis.

Authors:  Sung-Ung Moon; Hyung-Hwan Kim; Tong-Soo Kim; Kyung-Mi Choi; Chang-Mi Oh; Yong-Joo Ahn; Seo-Kyoung Hwang; Youngjoo Sohn; E-Hyun Shin; Hyuck Kim; Hyeong-Woo Lee
Journal:  Clin Vaccine Immunol       Date:  2010-06-16

3.  Investigation into the biological properties of the olive polyphenol, hydroxytyrosol: mechanistic insights by genome-wide mRNA-Seq analysis.

Authors:  Haloom Rafehi; Andrea J Smith; Aneta Balcerczyk; Mark Ziemann; Jenny Ooi; Shanon J Loveridge; Emma K Baker; Assam El-Osta; Tom C Karagiannis
Journal:  Genes Nutr       Date:  2011-09-28       Impact factor: 5.523

4.  Role of heme oxygenase-1 in human endothelial cells: lesson from the promoter allelic variants.

Authors:  Hevidar Taha; Klaudia Skrzypek; Ibeth Guevara; Anneliese Nigisch; Stefan Mustafa; Anna Grochot-Przeczek; Pawel Ferdek; Halina Was; Jerzy Kotlinowski; Magdalena Kozakowska; Aneta Balcerczyk; Lucie Muchova; Libor Vitek; Guenter Weigel; Jozef Dulak; Alicja Jozkowicz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-05-27       Impact factor: 8.311

5.  Alpinia katsumadai H(AYATA) seed extract inhibit LPS-induced inflammation by induction of heme oxygenase-1 in RAW264.7 cells.

Authors:  Mee-Young Lee; Chang-Seob Seo; Jin-Ah Lee; In-Sik Shin; Su-Jeong Kim; HeyKyung Ha; Hyeun-Kyoo Shin
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

6.  Macrophage metabolic adaptation to heme detoxification involves CO-dependent activation of the pentose phosphate pathway.

Authors:  Gael F P Bories; Scott Yeudall; Vlad Serbulea; Todd E Fox; Brant E Isakson; Norbert Leitinger
Journal:  Blood       Date:  2020-09-24       Impact factor: 22.113

7.  Repression of Nrf2/ARE regulated antioxidant genes and dysregulation of the cellular redox environment by the HIV Transactivator of Transcription.

Authors:  Ari Simenauer; Betelhem Assefa; Jose Rios-Ochoa; Kara Geraci; Brooks Hybertson; Bifeng Gao; Joe McCord; Hanan Elajaili; Eva Nozik-Grayck; Adela Cota-Gomez
Journal:  Free Radic Biol Med       Date:  2019-06-22       Impact factor: 7.376

8.  Anti-inflammatory activity of Barleria lupulina: Identification of active compounds that activate the Nrf2 cell defense pathway, organize cortical actin, reduce stress fibers, and improve cell junctions in microvascular endothelial cells.

Authors:  Donald R Senger; Mien V Hoang; Ki Hyun Kim; Chunshun Li; Shugeng Cao
Journal:  J Ethnopharmacol       Date:  2016-09-20       Impact factor: 4.360

9.  Heme oxygenase-1 attenuates ovalbumin-induced airway inflammation by up-regulation of foxp3 T-regulatory cells, interleukin-10, and membrane-bound transforming growth factor- 1.

Authors:  Zhen-Wei Xia; Li-Qing Xu; Wen-Wei Zhong; Jing-Jing Wei; Ning-Li Li; Jie Shao; Yun-Zhu Li; Shan-Chang Yu; Zi-Li Zhang
Journal:  Am J Pathol       Date:  2007-11-08       Impact factor: 4.307

Review 10.  Therapeutic potential of HO-1 in autoimmune diseases.

Authors:  Bao-Zhu Li; Biao Guo; Hai-Yan Zhang; Juan Liu; Sha-Sha Tao; Hai-Feng Pan; Dong-Qing Ye
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.